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The success of Mycobacterium tuberculosis as a deadly 
pathogen lies in its ability to survive under adverse 
conditions during pre- and post-infectious stages. The 
transcription process and the regulation of gene  
expression are central to the survival of the pathogen 
through the harsh conditions. Multiple sigma factors, 
transcription regulators, diverse two-component sys-
tems contribute in tailoring the events to meet the 
challenges faced by the pathogen. Although the ma-
chinery is conserved, many aspects of transcription 
and its regulation seem to be different in mycobacteria 
when compared to the other well-studied organisms. 
Here, we discuss salient aspects of transcription and 
its regulation in the context of distinct physiology of 
mycobacteria. 
*For correspondence. (e-mail: vraj@mcbl.iisc.ernet.in) 
 
Keywords: Mycobacteria, pathogen, transcription  
regulators. 
Introduction 
FROM the time Mycobacterium tuberculosis was identi-
fied as the causative agent for tuberculosis, understanding 
the organism and controlling the devastating disease has 
been one of the major challenges. The organism contin-
ues to be the leading pathogen posing a serious threat, de-
fying all measures to counter the infection. With millions 
getting afflicted each year, countering the organism and 
the treatment of the disease poses a great challenge. The 
pathogen continues to torment mankind, retaining the 
status of number one global killer. Its slow growth rate, 
formidable cell wall, latency and development of resis-
tance to multiple drugs are only some of the hurdles pre-
sented by the organism, discussed and deliberated in 
scientific panels and other forums on basic biology as 
well as in clinical setting1–6. The exceptional success of 
the microbe lies in its inimitable lifestyle and the design 
of nearly perfect mechanism of pathogenesis. M. tubercu-
losis has evidently evolved elaborate strategies to over-
come the adverse conditions faced during infection 
periods by efficiently modulating its regulatory network, 
gene expression, transport and signalling5,6. The nexus  
between M. tuberculosis and human immunodeficiency 
virus and the emergence of multiple drug-resistant strains 
has further aggravated the problem and demands massive 
counter measures to tackle it at various levels7. 
 Although the study of the organism was a daunting 
challenge, efforts have been made over the last several 
decades to combat the disease and to understand the bio-
logy of the organism. These are summarized in the cited 
reviews and book chapters1–4. This early work was fol-
lowed by several studies on the intermediary metabolism 
of the organism and molecular processes. Advent of 
newer approaches in the last few decades has led to major 
efforts to understand the organism better and also newer 
strategies to develop anti-tubercular molecules8–11. In this 
review, we summarize the more recent progress made to 
understand transcription in mycobacteria, one of the cen-
tral processes in all the organisms with emphasis on the 
events during the initiation step. 
RNA polymerase, the molecular machine of  
transcription 
Transcription in bacteria is initiated after binding of the 
RNA polymerase (RNAP) to promoter DNA and melting 
of 12–14 base-pairs around the transcription start site to 
form a single-stranded ‘transcription bubble’ within a 
catalytically active RNAP–DNA open complex (RPo). 
Initiation involves a series of sequential steps illustrated  
 
 
 
 
Figure 1. Schematic of transcription initiation pathway. When a pro-
moter (P) is encountered by the RNA polymerase (RNAP) after the 
search, the enzyme forms a reversible complex with the DNA (closed 
complex, RPc). A series of steps involving the separation of strands at –
10 region results in a number of different intermediates collectively 
represented as RPint. The conformational changes in DNA and RNAP 
eventually lead to the formation of open complex (RPo). Binding of initiat-
ing ribonucleotides (iNTPs) to the complex leads to the formation of initia-
tion complex (RPI) having nascent RNA dinucleotide. The dinucleotide is 
extended into small RNA products (abortive transcription) and finally into 
the growing chain of productive RNA message by elongating RNAP 
(RPe). Solid arrows, kinetic events; dotted arrows, equilibrium events; 
KB, equilibrium binding constant; Kd, equilibrium dissociation con-
stant; k′, association constant; koff, dissociation constant. 
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in Figure 1. All bacterial RNAPs have the subunit com-
position σ, β, β ′, 2α, ω and the mycobacterial enzyme is 
no exception12,13. Being a principle component of the es-
sential process of transcription, one would expect the sub-
units of the core polymerase to be well conserved and 
that is indeed the case14. The major difference emerges in 
the sigma subunit composition as mycobacteria possess 
an unusually large number of sigma factors including the 
primary sigma factors, required for the transcription of a 
majority of the genes necessary for the housekeeping 
functions and alternative sigma factors, which direct the 
transcription initiation of genes involved in specialized 
functions15–18. Out of the 13 sigma factors in M. tubercu-
losis, SigA, B and F are representatives of the primary 
group, i.e. they belong to Sig 70 family16, whereas others 
are grouped as alternative sigma factors. A number of 
them in the latter group have the characteristic features of 
extra-cytoplasmic factors (ECF)15–18. Table 1 summarizes 
the available information regarding the recognition se-
quence of each of the sigma factors, their function and re-
sponse to different conditions including environmental 
and stress. Unlike in Escherichia coli, a majority of these 
sigma encoding genes seem to be expressed in the expo-
nential phase although at varied levels15,16,19,20. For exam-
ple, the qRT-PCR studies revealed that SigC transcripts 
were at the highest level followed by SigA, B, D, E 
mRNAs whereas SigF, H and M mRNAs were found to 
be present in lower levels16. Among these, the levels of 
SigA transcripts remained almost constant throughout the 
growth phases and in different stresses except during star-
vation and low aeration16. Alteration in the levels of the 
ECF sigma transcripts in response to different stress indi-
cates their involvement in regulation of stress-specific 
genes (Table 1). A number of these sigma factor tran-
scripts are translated during the exponential phase itself. 
Western blotting using antibodies against the SigA, B, E, 
F, L and H indicated their presence albeit at varied lev-
els13. Although SigC mRNA was found to be abundant in 
exponential growth phase16, no information regarding the 
level of the protein is available. However, the presence of 
SigA and B proteins in nearly equal quantity emphasizes 
their role as major factors for transcription from a large 
number of promoters in exponential phase13. The expres-
sion pattern of these sigma factors appears to be vastly 
different from any other bacteria, particularly E. coli20. 
For example, RpoS, the stationary phase sigma factor in 
E. coli is expressed in higher levels only during the star-
vation and stress conditions. SigB, which is considered to 
be a homologue of RpoS of E. coli, is expressed abun-
dantly in exponential phase and the level goes up further 
at the later stages of growth or under stress condi-
tions16,20,21 (Table 1). Why SigC mRNA is present in high 
quantity in the exponential phase given that it belongs to 
the group of alternate sigmas, is not known. Notably, 
sigC mutation decreased the expression of a large number 
of genes suggesting its important role. The availability of 
the mRNA for immediate translation when needed could 
be a regulatory strategy as seen in the case of SigH tran-
scripts in E. coli22. From the above discussion, it is evi-
dent that a number of diverse promoters are transcribed 
by their specific sigma factors even in exponential phase. 
Expression and utilization of alternative sigma factors 
during all phases of growth reflect the ability of the or-
ganism to adapt to various environmental and stress con-
ditions. However, a number of these sigma factors are 
subjected to regulation by anti-sigma or even anti-anti 
sigma and other factors (Figure 2). Thus it is conceivable 
that being a clever pathogen, M. tuberculosis has tailored 
its transcription machinery to adjust to the changing envi-
ronment rapidly during pre- and post-infection stages. 
 However, the expression of most of the sigma factors, 
if not all, during the exponential phase itself poses a pro-
blem for in vitro studies with the enzyme, especially in 
understanding the RNAP structure or specific gene tran-
scription and analysis of the interaction of a particular 
promoter with the polymerase. Purified RNAP prepara-
tions from mycobacteria are a mixture of several holo-
enzymes although proportion of sigma subunits is highly 
varied13. SigA containing holo-enzyme constitutes only 
about 30% of the population hampering the quantitative 
in vitro transcription studies13. Although cloning, het-
erologous expression in E. coli, purification and reconsti-
tution of the enzyme is achieved by different groups, 
these preparations had lower specific activity and were 
found to be unsuitable for quantitative in vitro studies13. 
To overcome this serious problem, we over-expressed 
SigA in Mycobacterium smegmatis and isolated holo-
enzyme with near stoichiometric amounts of the factor13. 
This was also facilitated by a M. smegmatis strain in 
which rpoC gene encoding β ′ subunit of the enzyme was 
chromosomally His tagged for the facile purification of 
the enzyme23. Such a single sigma subunit enriched holo-
enzyme has enabled promoter-specific transcription stud-
ies described in the next section. 
Promoter architecture in mycobacteria and  
promoter–polymerase interactions 
The existence of a large number of sigma factors for tran-
scription initiation also points at the diversity of the pro-
moters in the mycobacteria. In contrast to E. coli where, 
G or A are predominantly the transcription start site,  
mycobacterial RNAP prefers G as the initiating nucleo-
tide for synthesis of RNA24,25. A matrix for –35 and –10 
elements recognized by these factors has been generated 
based on the sequence analysis of the promoters func-
tional under different conditions25. Based on these stud-
ies, it appears that the SigA recognized promoters have  
–10 element resembling that of E. coli Sig70 consensus 
but a less conserved –35 sequence25 (Table 2). The con-
sensus sequence for the promoters of most of the sigma 
factors in mycobacteria has been elucidated (Table 2). 
Based on the architecture and sigma factors involved in
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Table 1. Consensus sequence of sigma factors, levels in different conditions and their roles 
 Consensus 
Sigma –35---spacer---10 Response to stress Functions Ref. 
 
SigA TTGACW---N18---TATAMT Phagocytosis, low aeration, House-keeping, essential 25, 83, 84 
    starvation        ↑  for virulence  
 
SigB NGTGG---N14–18---NNGNNG Heat shock, SDS, oxidative   ↑ Adaption to carbon starvation and 85 
   stress          ↓  general stress response 
 
SigC SSSAAT---N16–20---CGTSSS Stationary phase, heat shock, Virulence, maintenance of toxicity  86, 87, 88 
    cold shock, oxidative, surface 
    stress                 ↓ 
 
SigD GTAACGct---AT rich stretch Starvation                              ↑ Survival during nutrient deprivation. 89 
    Stringent response  
 
SigE gGGAACYa–N15–16–cGTT Heatshock, SDS exposure, Growth in macrophages, response to 
    vancomycin stress              ↑  heat shock, oxidative stress 19, 90, 91 
 
SigF GGWWT–N16–17–GGGTAY Anaerobic, antibiotic, metronidazole, Cell wall synthesis, growth during 
    nutrient deprivation            ↑  starvation 92–94 
 
SigG GCGNGT–N15–18–CGANCA Macrophage infection            ↑ Growth in macrophages and 92 
     SOS response 
 
SigH gGGAAYA–N16–17–cGTT Heat shock, diamide stress, Histopathology, host immune 95, 96 
    macrophage infection        ↑  response, heat shock response 
 
SigJ GTCACA–N16–CGTCCT Stationary phase, growth Oxidative stress response 97, 98 
    in macrophage                     ↑ 
SigK CCATCC–N15–CCGAAT *NA *NA 99 
SigL TGAACC–N16–18–CGTCR *NA Oxidative and detergent stress 100 
SigM GGAAC–N16–18–CGTCR Stationary phase and heat shock ↑ Expression of four esat-6 genes 101 
*NA – Not available, ↑, upregulation, ↓, down regulation. R-A/G; W-A/T; M-A/C; S-C/G; Y-C/T. 
 
 
 
 
Figure 2. Sigma factors regulatory network in M. tuberculosis. The participating proteins are repre-
sented in different shapes and colors. For example, sigma factors are in different shades of blue. Out of 
thirteen sigma factors in the genome, information is not available for three. Double headed arrow indi-
cates inhibition by physical sequestration; single headed arrow indicates regulation which could be either 
positive or negative. MprA is a response regulator of the two component system, MprAB; ppK, poly-
phosphate kinase. 
 
recognition, the mycobacterial promoters have been cate-
gorized into four groups, viz. A, B, C and D. Those in 
group A have both, –35 and –10 elements similar to E. 
coli Sig70 consensus25, whereas the promoters catego-
rized in group B do not have a conserved –35 element3. 
Promoters in group A include principle promoter PrrnPCL1
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Table 2. Classification of mycobacterial promoters 
Group Organism Consensus Ref. 
 
Group A M. tuberculosis T62T42G76A66C71A33---T76A81K66R66A42T81  25 
 M. smegmatis T73T58G68A26C57A36---T94A84T63A42A42T78   
 
Group B M. tuberculosis *NC---T80A80G50G50C60T99  3 
 M. smegmatis *NC---T85A85NA57C42T71   
 
Group C M. tuberculosis *NC---NC 31, 32 
 M. smegmatis   
 
Group D M. tuberculosis T91G64C55C55G73T27---C82R72S90C45M63S90 25 
 M. smegmatis   
*Not conserved, R-A/G, W-A/T, M-A/C, S-C/G, Y-C/T. 
 
 
and PrrnB of rrn operons26,27, initiator tRNA promoter, 
PmetU (ref. 28) and the principle promoter of gyr operon, 
PgyrB1 (ref. 25). Promoters transcribing ideR, erp, purL  
belong to group B promoters3,29,30. Group C is constituted 
by the promoters which do not resemble the E. coli con-
sensus and control the transcription of regulated genes 
encoding HSP60 and GroEL1 (refs 3, 31, 32). Group D 
includes the promoters having unusual hexamer elements. 
One of them, termed SigGC promoter found upstream of 
gyr A was the first member to have these sequences25. 
The –35 and –10 elements of the promoter are highly GC 
rich and no cognate sigma factor has been identified so 
far. Subsequently, par genes of Mycobacterium bovis and 
M. smegmatis involved in partitioning of plasmids and 
chromosomes were shown to have these unusual GC rich 
promoter sequences33. 
 Occurrence of a large number of sigma factors and  
diverse promoter architecture indicate a complex pattern 
of promoter–polymerase interaction. With the develop-
ment of optimized RNAP preparation enriched with 
SigA, the in vitro analysis of specific promoter–
polymerase interaction has become feasible and the  
kinetic analysis of transcription initiation has been car-
ried out. The information from these studies has provided 
key insights into the individual steps of the process to un-
ravel the regulation of the synthesis of stable RNA and 
enzymes having housekeeping functions. 
 In the total RNA pool of the cell, rRNA transcripts 
constitute the major fraction34–36. Rest of the bulk is con-
tributed by the other stable RNA, tRNA and transcripts 
for house-keeping essential functions, which are also 
driven by efficient promoters36. A majority of bacteria 
possess multiple operons for rRNA with more than one 
promoter to transcribe each operon34–38. Some of the 
eubacteria have one or more rrn operons located near to 
oriC, an arrangement to take advantage of the gene-
dosage effect during replication39,40. Fast growing bacte-
ria such as E. coli and Bacillus subtillis have seven and 
ten rRNA operons respectively, driven by two promoters 
in all the operons36–39. However, all the members of the 
genus mycobacteria do not have the luxury of possessing 
multiple rrn operons26,27,41,42. The number of rrn operons 
varies from one or two depending on the growth rate of 
the members of the genus27,41,42. The slow growers have 
only one while the fast growers have two operons, to 
cope up with their growth characteristics27. Most notably, 
in many species, transcription is driven by several pro-
moters ranging from two to four26,27,41,42, thus having 
flexibility to generate more rrn transcripts when needed, 
depending upon the cellular requirements. As if to suit its 
very slow growth rate, M. tuberculosis has single operon, 
that too located about 1,500 kb away from the oriC40. 
However, two promoters P1 and PCL1 drive the tran-
scription from the operon. In contrast, in M. smegmatis, a 
fast grower, the entire requirement of rRNA transcripts is 
met by two rRNA operons27,41,42. Of the two operons, 
rrnBf is driven by a single promoter PrrnB, whereas the 
second operon rrnAs has three promoters P1, P2 and 
PCL1 (ref. 27). Besides the difference in the distribution, 
rrn promoters from the two organisms also show distinct 
properties43,44. For example, PrrnPCL1, the principle pro-
moter of rrnAs operon in both M. smegmatis and M. tu-
berculosis differs in the kinetics of transcription initiation 
and promoter activity between the two species43,44. The 
rate limiting step at M. tuberculosis PrrnPCl1 was found to 
be the stability of the open complex, whereas the pro-
moter clearance was the slowest step in M. smegma-
tis43,44. Both promoters respond to the small molecule 
regulators, initiating NTPs (iNTPs) and guanosine penta-
phosphate (pppGpp), albeit to a different extent. iNTPs 
upregulate while pppGpp downregulates the transcription 
from these promoters43,44. The action of these regulators 
at rRNA promoters alters their strength in different 
growth phases. A GC rich sequence between –10 and 
transcription start site termed as discriminator is an im-
portant element in determining the response of the pro-
moters to these small molecule regulators in E. coli45. 
Previous studies with the rrn promoters of mycobacteria 
reported a lack of discriminator sequences39,46. However, 
we have considered the existence of an alternate dis-
criminator sequence in promoters of mycobacteria that 
are subjected to regulation by iNTPs and pppGpp. Indeed 
our ongoing analysis suggests the presence of different 
sequence determinants not only in rRNA operons, but 
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also in other promoters regulated by growth phase de-
pendent control of gene expression (Tare and Nagaraja, 
MS in preparation). In addition to these unique sequence 
determinants, rRNA operon may also be differentially 
controlled by regulators that act in a manner unique to the 
organism. In E. coli, the cis-acting AT-rich UP elements 
and a nucleoid associated protein, Fis are involved in in-
creasing the transcriptional efficiency of rrn promoters, 
adding another layer of regulation47,48. However, neither 
an AT rich UP element upstream of the operon nor a Fis 
homologue has been identified in mycobacteria40,49.  
Involvement of additional elements and regulatory pro-
teins, if any, in rRNA regulation of mycobacteria is yet to 
be explored. 
 PmetU is one of the strong promoters in M. tuberculosis 
and M. smegmatis, encoding the crucial initiator tRNA 
responsible for translation initiation28. Unlike its E. coli 
counterpart, it is not arranged as an operon and is present 
in a single copy in both the species, representatives of 
fast and slow growing mycobacteria respectively28. Al-
though these two organisms have different number of 
rRNA operons to suit their growth needs, presence of a 
single functional initiator tRNA gene in both of them is 
rather intriguing26–28,41,42. However, M. smegmatis PmetU is 
stronger than its counterpart in M. tuberculosis28, which 
would allow synthesis of higher amounts of transcripts to 
cope up with the needs of faster dividing cells. Another 
surprising feature of the initiator tRNA promoters is their 
insensitivity towards iNTPs and pppGpp44 (Tare et al., 
unpublished data). The inhibition of the single promoter 
of an essential component during stationary phase could 
be detrimental for cell survival which may explain in part 
why these promoters are unresponsive to iNTP/pppGpp 
mediated regulation. 
 Gyrase promoters illustrate yet another example where 
the transcription machinery seems to be adapted differ-
ently to meet the needs posed by the distinct lifestyle of 
mycobacteria. Gyrase, a type II topoisomerase is a het-
erodimer of GyrA and GyrB, required to maintain the su-
percoiling homeostasis of the genomes of all 
eubacteria50,51. The transcriptional unit for the two 
genes – gyrB and gyrA in mycobacteria is arranged as an 
operon, an organization distinct from E. coli and many 
other organisms where the two genes are present at sepa-
rate loci, far apart from each other25. In M. smegmatis, the 
dicistron is directed by a single promoter, whereas the M. 
tuberculosis gyr operon has multiple promoters25,52. The 
principle promoter PgyrB1 is accompanied by an overlap-
ping and divergent promoter PgyrR. The –35 and –10 ele-
ments of the principle promoter are similar to the SigA 
recognized sequences, but the promoter elements at PgyrR 
do not resemble the consensus25. The reverse promoter 
which was shown to be 13 times weaker than the princi-
ple promoter may have an important function in the regu-
lation of transcription at gyr operon in the conditions that 
alter the topology of the cell25 (see later section). Besides 
the differences in the organization, the promoters of  
M. tuberculosis and M. smegmatis show distinct rate lim-
iting steps during transcription initiation and regula-
tion43,44. While the kinetics of open complex formation at 
Pgyr of M. smegmatis is slower43, M. tuberculosis PgyrB1 is 
rate limited at promoter clearance step44, similar to E. coli 
gyr promoters53, highlighting subtle differences exhibited 
by promoters from closely related species transcribing the 
same gene. In this regard, a hitherto unknown mode of 
gyrase regulation during transcription initiation of the op-
eron appears to contribute to the maintenance of distinct 
lifestyle of M. tuberculosis. The activity of the M. tuber-
culosis PgyrB1 is maximum in the exponential phase and 
decreases in the stationary phase rendering the promoter 
sensitive to the growth phase dependent regulation and 
respond to the small molecule effectors of the regulation, 
iNTPs and pppGpp44. This sensitivity to iNTPs and 
pppGpp seen with M. tuberculosis gyrase promoter is not 
observed for gyr promoters from M. smegmatis, E. coli or 
any other organism studied so far43,44,53,54. 
 Apart from the growth phase-dependent regulation, the 
synthesis of gyrase mRNA is subjected to another layer 
of regulation termed as relaxation stimulated transcription 
(RST). This regulatory strategy is an adaptation to allow 
the homeostatic maintenance of the levels of gyrase53,54. 
In this mechanism, the transcription from the gyrase pro-
moters is stimulated in response to relaxed status of the 
genome53. Unlike growth phase dependent control which 
seems to be incorporated only to M. tuberculosis gyr 
promoters, RST seems to be occurring at gyr promoters 
of E. coli, M. smegmatis and M. tuberculosis, though the 
mechanism appears to be different. In M. smegmatis for-
mation of Cruciform Hairpin Palindromic Structure 
(CHPS) with an 8-base pair stem and a 4-base loop in the 
5′ translated region results in inhibition of transcription 
when the genome is negatively supercoiled. As the  
genome gets relaxed, the structure is resolved, relieving 
the inhibition. In addition, studies in the plasmid context 
have shown that DNA elements present at 600 bp down-
stream within the ORF are essential for the response  
of the promoter to RST in M. smegmatis52. The exact 
mechanism by which both, promoter distal and proximal 
elements play a role in RST is yet to be elucidated. In M. 
tuberculosis, RST operates at a slower rate and the ele-
ments shown to be crucial for the response in M. smeg-
matis are not involved25,52. Rather, the overlapping 
promoters appear to contribute to RST. The overlapping 
and divergently oriented promoter PgyrR could potentially 
occlude the binding of RNAP at the principle promoter in 
gyr operon reducing the transcription. Earlier study with 
the promoter provided evidence that in spite of the  
absence of any ORF downstream to PgyrR, the RNAP at 
divergent promoter directs the transcript synthesis. The 
negative supercoiling appears to increase the transcription 
from the weaker promoter with a concomitant decrease at 
the PgyrB1 (ref. 25). 
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Role of transcription factors 
During transcription initiation and elongation, distinct 
sets of transcription factors associate with various sub-
units of RNAP to modulate the DNA binding and cata-
lytic properties. Between the initiation and elongation 
phases of the cycle, many of the factors have to be  
exchanged to ensure the continuation and completion of 
the process. In most of the promoters, the control of tran-
scription initiation is not confined to promoter–
polymerase interactions, but rather subjected to the action 
of the regulators that act either positively or negatively to 
influence the process. From the genome analysis of M. 
tuberculosis and related bacteria, it is apparent that more 
than 100 proteins are involved in the regulation of tran-
scription40. Although the number appears to be smaller 
compared to the factors characterized in E. coli, B. subtil-
lis and other well-studied organisms, very little is known 
about their function and molecular mechanism of action. 
From the studies carried out by several groups, it is  
evident that a number of regulatory factors are being 
characterized. Some of these factors are found only in 
mycobacteria and related species (WhiB family, DevR, 
CarD), whereas others are conserved in other bacteria as 
well. In the following section, we deal with a few of these 
factors, whose role has been subjected to detailed investi-
gation. Broadly, these factors could be fitted into two 
groups – those which bind RNAP and influence the proc-
ess during initiation, elongation and termination and the 
second set that bind to DNA to exert their regulatory role 
either positively or negatively. We are confining the fol-
lowing brief discussion to a few of the regulators that 
bind specific sequences in the DNA to exert global gene 
expression control and another selected set of factors that 
bind to the polymerase to influence its function. The  
factors and conditions responsible for the induction or  
activation of the regulatory proteins are presented in  
Table 3. 
 Cyclic AMP receptor protein (CRP) is one of the most 
well studied global regulators of transcription55,56. The 
protein gets activated after binding of cAMP. CRP binds 
to 16 bp sequence and modulates the transcription of the 
target promoters in mycobateria56. The genes targeted by 
cAMP–CRP complex appear to be involved in the persis-
tence and/or emergence from the dormant state in M. tu-
berculosis as opposed to the genes involved in carbon 
metabolism in E. coli and number of other bacteria55,57,58. 
For example, CRP regulates the transcription of WhiB1 
and rpfA, genes having important functions in the growth 
cycle of M. tuberculosis57,59. The transcript of rpfA en-
codes a protein that is involved in reviving dormant bac-
teria, while the WhiB1 protein has a role in relaying the 
nitric oxide signal – a stress generated during the growth 
of the pathogen in macrophages60. WhiB1 is encoded by a 
gene belonging to the wbl family having seven genes 
numbered 1 to 7 (ref. 59). WhiB1 is sensitive to NO and 
when bound by the small molecule represses the tran-
scription from its own promoter59. Recently it has been 
shown to repress the transcription from GroEL2 promoter 
encoding the essential gene61. Based on the targets af-
fected by WhiB1, it appears that the protein is essential 
during the survival in macrophage and probably in main-
taining the dormant state of the bacteria. WhiB3 binds to 
the promoters of polyketide biosynthetic genes in redox-
dependent manner and regulates synthesis of inflamma-
tory polyketides62. Besides, the protein also interacts with 
SigA to affect the host survival63. Recent studies have 
shown the role of WhiB4 during oxidative stress and 
maintenance of the redox balance in the cells64. Although 
WhiB1, WhiB3 and WhiB4 are well studied, the roles of 
other WhiB proteins are still being elucidated61–64. All the 
seven proteins of the WhiB family are redox-sensitive 
owing to [Fe–S] clusters stably bound to them65. The 
gene products of the family play important role in differ-
ent physiological aspects of M. tuberculosis. These tran-
scription factors influence essential processes, viz. cell 
division, survival during nutrient deprivation, pathogene-
sis, drug resistance, sensing different stress and are 
unique to Mycobacterium, Streptomyces spp. and other 
related actinobacteria65. These roles of WhiB family of 
proteins shed light on their exclusive function in complex 
physiology of mycobacteria. The key requirement of iron 
during infectious stages of the organism is yet another 
aspect of the unique lifestyle of mycobacteria. Iron is 
used as the cofactor for enzymes participating in the  
redox reactions. In humans, iron is majorly found in haem 
bound form and therefore the availability of iron for the 
pathogen is limited66. To compensate for the limited 
availability of usable iron in human blood, the pathogen 
produces siderophores, the high affinity metal chelators66. 
To regulate the amount of iron, which in higher amounts 
can be detrimental to the cells, mycobacteria contain a 
number of iron-dependent regulators. IdeR is one of those 
metallo-regulatory proteins, which is a DNA-binding 
transcription factor66. The genes regulated by IdeR in-
clude mbtA, mbtB, mbtl, rv3402c, bfd, bfrA, mmpL4 and 
mmpS4 and the list is likely to be much larger67. The IdeR 
controlled genes encode proteins with diverse functions 
such as transport and lipid metabolism. However, the 
primary targets of IdeR seem to be the ones involved in 
iron metabolism66. The essentiality of IdeR and its role  
in iron metabolism and oxidative stress response indi-
cates its role during the survival of M. tuberculosis  
in human system and modulating the transcription during 
the infection periods to aid in better survival of the orga-
nism. 
 Besides these regulators, M. tuberculosis is armed with 
11 two-component systems – a possible adaptation for its 
survival in the complex environment thereby modulating 
the gene expression in response to the diverse cues. Of 
these, PhoP–PhoQ and DevR–DevS are the most studied 
systems due to their regulatory effect on a large number 
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Table 3. Environmental conditions and factors responsible for activation/induction of transcription factors 
Regulators  Conditions and factors  Ref. 
 
CRP cAMP, macrophage infection   57 
CarD  Oxidative stress, DNA damage, starvation,   78 
   genotoxins, ciprofloxacin, H2O2 
DevRS  NO, hypoxia, dormancy  102 
IdeR  Excess iron   66 
PhoP  Low Mg2+, low pH, antimicrobial peptides   69 
RbpA  Stationary phase, aerated starvation, in vitro hypoxia, mouse macrophages,  82 
   heat shock, di-amide stress, dormant stages 103 
WhiB1  Hypoxia, cAMP, mice infection  104 
WhiB2*  cAMP   
WhiB3  Hypoxia, NO   
WhiB4  cAMP, mice infection   
WhiB5  cAMP   
WhiB6* Hypoxia, NO, macrophage infection   
WhiB7 Hypoxia, NO, mice and macrophage infection 
*WhiB2 and WhiB6 have been shown to be down-regulated during hypoxia and macrophage infection respec-
tively. 
 
 
of genes68–72. M. tuberculosis PhoP–PhoQ is essential for 
virulence and mutation in PhoP, the histidine kinase sen-
sor, leads to attenuation of the strain, possibly by prevent-
ing the secretion of enzymes important for virulence. 
Notably, among the sequence variations between M. tu-
berculosis H37Rv and H37Ra, a single base mutation in 
PhoP is also considered important for virulence. PhoP 
regulates about 114 genes and many of these are involved 
in lipid metabolism, secretion and several other func-
tions68,69. Another well-studied two-component system, 
DevR–DevS, is essential for survival of M. tuberculosis 
in host macrophages especially during dormancy. The ex-
pression of DevS, the sensory kinase of the two compo-
nent system is induced by NO and hypoxia. DevR – the 
response regulator, binds to DNA in cooperative manner 
after it gets phosphorylated to alter the expression of the 
target genes70. The sequence in DNA crucial for binding 
of the regulator protein is termed as Dev box and its pres-
ence is shown in the promoters of several genes and the 
list is expanding as more genes are predicted to be the 
targets of DevR70,71. More detailed information about the 
two-component systems and their crucial role has been 
described in several papers70–72. 
 A number of factors bind to RNAP at different stages 
of transcription. Among them, Nus factors and Rho could 
be considered as general factors that assist the enzyme 
during elongation and or termination. Although some  
information is available on some of the Nus factors, the 
function of transcription terminator factor Rho in M. tu-
berculosis is yet to be elucidated. At least two kinds of 
factors ensure that transcripts formed are devoid of any 
errors. Precise transcription by RNAP requires efficient 
removal of occasionally incorporated non-cognate  
nucleotide residues. Incorporation of a wrong nucleotide 
results in backtracking of transcription elongation com-
plex (TEC). Hydrolysis of the mis-incorporated nucleo-
tide at the 3′ end of the RNA and restoring the 
transcription elongation on track is a must to avoid dele-
terious consequences. Gre factors, originally named as 
transcript cleavage factors, assist RNAP active centre in 
the removal of mis-incorporated nucleotide to reset the 
process73. These transcription factors bind RNAP, ap-
proach the active centre Mg2+ through secondary channel 
and fine tune the centre to accelerate the proof reading 
process73. E. coli genome encodes two Gre factors (Gre A 
and B), both dispensable for the survival of the organ-
ism73,74. In contrast, a single Gre factor is found in the 
genomes of various mycobacteria and it seems to be  
essential for survival. The transcription factor enhances 
the inefficient promoter clearance and rescues the RNAP 
from a stalled complex to resume the transcription elon-
gation. Though the cleavage signature of the single Gre 
factor resembles that of GreA in E. coli, it did not interact 
with E. coli RNAP75. The C-terminal domain responsible 
for interacting with RNAP shows considerable variations, 
which may confer the species specificity to these factors. 
Another factor, Rv3788, which shows 21% similarity to 
M. tuberculosis Gre, seems to be yet another secondary 
channel-binding protein75,76. The homologues of this pro-
tein have been found only in slow-growing mycobacteria 
and absent in fast-growing members76. Similar to the Gre 
factors, Rv3788 has conserved residues at the tip of N-
terminal coiled coil domain75,76. Despite having similar  
domainal organization like Gre factors, the protein inhibited 
the transcription rather than inducing nascent transcript 
cleavage. The inability of the Rv3788 to induce cleavage 
may be attributed to reduced length of the N-terminus. The 
modulator binds at the entry site of the secondary channel, 
possibly competing with the binding of NTPs resulting in 
the transcription inhibition76. The exact mechanism of  
action of the inhibitor and environmental cues to which 
the protein responds are being elucidated. 
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 Another set of factors help in recruiting nucleotide  
excision repair machinery when the RNAP stumbles upon 
DNA damage in template DNA itself. Mfd, also termed 
as transcription repair coupling factor based on its func-
tion binds to stalled RNAP, displaces it from the site of 
damage to recruit the repair machinery. Our studies  
reveal that although M. tuberculosis Mfd is similar to  
E. coli factor in many respects, some of its unique features 
may have important role during transcription elongation 
on GC-rich templates of mycobacteria77. Unlike in E. coli 
and other well studied systems, mycobacterial Mfd is 
found to be hexameric both in vitro and in intracellular 
milieu, suggesting its additional role in mycobacteria77. 
 CarD, a highly expressed protein in M. tuberculosis 
and M. smegmatis is a modulator of transcription at many 
promoters including rrn and ribosomal proteins. The  
expression of CarD is stimulated under the conditions of 
stress and starvation78,79. CarD is essential for viability of 
M. tuberculosis and for persistence during infection. The 
protein binds at β subunit of RNAP and functions in a 
way similar to DksA of E. coli by affecting the stability 
of RNAP at rrn promoters78,79. Depletion of the essential 
protein causes sensitivity to oxidative stress, starvation, 
DNA damage and accumulation of rRNA transcripts. The 
essentiality of the two secondary channel-binding pro-
teins, Gre and CarD in M. tuberculosis hint at their 
moonlighting functions. It has been suggested that they 
may serve to resolve the conflict between advancing 
replisome and transcription assembly78. Absence of the 
protein would therefore adversely affect the replisomes 
causing DNA damage leading to the cell death. However, 
this idea remains to be tested and established. 
 A novel RNAP binding factor, RbpA has been identi-
fied in some species of mycobacteria and Streptomyces 
and it seems to be confined to Actinomycetes. Though it 
is dispensable for Streptomyces, its essentiality in M. tu-
berculosis has been demonstrated80. In studies with S. 
coelicolor, RbpA was shown to alter the sensitivity of 
RNAP to rifampicin at rRNA promoters81. In yet another 
analysis using M. smegmatis RNAP, it was shown to bind 
close to the antibiotic-binding site excluding the drug 
from its site82. However, with M. tuberculosis RNAP, 
RbpA does not prevent rifampicin binding and the inter-
action is mapped to a distant site. The factor binds to β 
subunit of RNAP at a new target for activation – Sand-
witch Barrel Hybrid Mottif (SBHM), a location distinct 
and far from rifampicin-binding residues80. Binding of 
RbpA to RNAP increases the longevity of the enzyme at 
PrrnPCL1. It has been suggested that the protein enhances 
the binding affinity of SigA to the core RNAP to increase 
the transcription efficiency at the rrnA promoter. The 
working hypothesis of the latter study is that the stimula-
tion of housekeeping gene expression may be the primary 
criteria for rifampicin tolerance and for adaptation to 
various stress during the infection. Although the mecha-
nism by which the protein alters the response of cells to 
rifampicin is not completely understood, the effect of 
RbpA on transcription machinery and its indispensible 
nature hints at its significant role. 
Conclusions 
The studies on the transcription and its regulation in myco-
bacteria have provided substantial new insights into the 
sequential events and the main components that partici-
pate in the process. To begin with, abundance of sigma 
factors indicates a larger diversity in promoter recogni-
tion. The over representation of ECF sigma factors sug-
gests the ability of the organism to respond to a variety of 
environmental stimuli. Presence of a large number of 
holo-enzyme species (core + different sigma factors) ren-
ders the transcription analysis more challenging. Function 
of a large number of regulatory proteins that may act as 
global or gene-specific factors is yet to be elucidated. 
Understanding the process and the elucidation of the 
mechanism of transcriptional regulation are the key  
advances likely to occur in the next few years. These de-
velopments would in turn facilitate the identification or 
development of the new inhibitors of the essential pro-
cess – an important step in future drug-discovery efforts. 
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